Disease control should be the goal of therapy for WM patients
Author:
Affiliation:
1. Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Publisher
American Society of Hematology
Subject
Hematology
Link
http://ashpublications.org/bloodadvances/article-pdf/1/25/2483/879171/advances005645.pdf
Reference22 articles.
1. Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia;Leblond;Blood,2016
2. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop;Owen;Br J Haematol,2013
3. Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy;Kastritis;Haematologica,2015
4. Ibrutinib in previously treated Waldenström’s macroglobulinemia;Treon;N Engl J Med,2015
5. Treatment of Waldenstrom’s macroglobulinemia with rituximab: prognostic factors for response and progression;Dimopoulos;Leuk Lymphoma,2004
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Zanubrutinib in Waldenström Macroglobulinemia;Journal of Clinical Oncology;2024-02-01
2. Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing;American Journal of Hematology;2023-03-20
3. Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia;Journal of Clinical Oncology;2021-02-20
4. Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up;Blood Advances;2020-08-21
5. Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis;OncoTargets and Therapy;2019-04
Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3